Gastrointestinal Cancer Articles

Tailored Approaches Offer Curative Potential to CRC Subsets
Michael J. Overman, MD, discusses an immunotherapy combination regimen in metastatic colorectal cancer and highlights existing challenges that still need to be addressed in future research.
Targeted Treatments Usher in Individualized Care in mCRC
Jonathan Mizrahi, MD, discusses recent pivotal data in colorectal cancer and its impact on personalized care in the treatment paradigm.
FDA Approvals Represent New Wave of Progress in Advanced HCC
Benjamin Leon Musher, MD, reflects on the progress that has been made in hepatocellular carcinoma and highlights promising combinations that are emerging in the space.
Genetic Testing Recommended for All Patients With Pancreatic Cancer
In a provisional clinical opinion, an expert panel convened by the American Society of Clinical Oncology has recommended that patients with pancreatic cancer undergo assessment of risk for hereditary syndromes that contribute to higher likelihood of pancreatic cancer.
Margaret A. Tempero, MD, discusses the impact of FOLFIRINOX in the treatment of patients with metastatic pancreatic cancer and sheds light on the importance of molecular profiling in the space.
Pancreatic Cancer Field Pushes Forward Following Pivotal Trial Readouts
Jordan D. Berlin, MD, sheds light on current and future directions in the field of locally advanced pancreatic cancer.
Lutathera Fills Unmet Need in NETs, Role of Radiation Expands Across GI Cancers
Derek R. McHaffie, MD, discusses the role of radiation therapy in the treatment of gastrointestinal cancers and the impact of radionuclide therapy in patients with neuroendocrine tumors.
Immunotherapy Shakes Up Gastric/GEJ Cancer Space, Alongside Angiogenic, Cytotoxic Agents
J. Stuart Salmon, MD, highlights first-, second-, and third-line treatment options for patients with gastric and gastroesophageal cancer following recent clinical trial findings and regulatory approvals.
Novel Therapies Lower Symptom Burden, Improve Survival in NETs
Kunal C. Kadakia, MD, highlight key takeaways from the the PROMID, CLARINET, and NETTER-1 trials and explains how their findings have been applied to clinical practice.
Therapeutic Options Available for Pancreatic Cancer, HCC Lead to New Challenges
Jimmy J. Hwang, MD, sheds light on updates in both metastatic pancreatic cancer and advanced hepatocellular carcinoma that have created new complexities for researchers.
Publication Bottom Border
Border Publication